We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current EKSO market cap is 13.83M. The company's latest EPS is USD -0.6909 and P/E is -0.88.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 4.61M | 4.85M | 3.76M | 4.95M | 4.13M |
Operating Income | -2.93M | -3.45M | -3.26M | -2.34M | -2.64M |
Net Income | -3.37M | -3.21M | -3.43M | -2.42M | -2.07M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 13.92M | 8.88M | 11.25M | 12.91M | 18.28M |
Operating Income | -16.64M | -13.29M | -14.71M | -15.56M | -15.11M |
Net Income | -12.13M | -15.83M | -9.76M | -15.08M | -15.2M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 31.18M | 28.92M | 28.96M | 26.98M | 29.21M |
Total Liabilities | 15.93M | 16.31M | 14.91M | 14.93M | 14.34M |
Total Equity | 15.26M | 12.61M | 14.05M | 12.06M | 14.87M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 21.92M | 20.6M | 49.17M | 40.9M | 28.92M |
Total Liabilities | 15.12M | 16.16M | 11.95M | 15.46M | 16.31M |
Total Equity | 6.8M | 4.43M | 37.22M | 25.44M | 12.61M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -10.47M | -15.72M | -3.47M | -6.14M | -8.41M |
Investing | -114k | -157k | -8k | -8k | -16k |
Financing | N/A | 348k | 3.66M | 3.39M | 8.08M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -15.77M | -8.76M | -11.16M | -14.69M | -15.72M |
Investing | -60k | N/A | -59k | -5.18M | -157k |
Financing | 19.04M | 10.7M | 38.71M | N/A | 348k |
Market Cap | 13.83M |
Price to Earnings Ratio | -0.88 |
Price to Sales Ratio | 0.73 |
Price to Cash Ratio | 2.02 |
Price to Book Ratio | 1.06 |
Dividend Yield | - |
Shares Outstanding | 22M |
Average Volume (1 week) | 90.95k |
Average Volume (1 Month) | 131.37k |
52 Week Change | -62.35% |
52 Week High | 3.1285 |
52 Week Low | 0.50 |
Spread (Intraday) | 0.01 (1.46%) |
Company Name | Ekso Bionics Holdings Inc |
Address |
8275 south eastern avenue las vegas, nevada 89123 |
Website | https://www.eksobionics.com |
Industry | general indl mach & eq, nec (3569) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions